MedPath

Formula PTX Renal Stent Clinical Study

Not Applicable
Completed
Conditions
Renal Artery Stenosis
Interventions
Device: Formula PTX Stent - Dose 3
Device: Formula PTX Stent - Dose 1
Device: Formula PTX Stent - Dose 2
Registration Number
NCT01057316
Lead Sponsor
Cook Group Incorporated
Brief Summary

The purpose of the study is to evaluate the safety and effectiveness of the PTX-coating on the Formula PTX Balloon-Expandable Stent in treatment of renal artery stenosis.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
120
Inclusion Criteria
  • renal artery stenosis
  • appropriate size and location of the lesion
Exclusion Criteria
  • pregnant or breast feeding
  • failure or inability to give informed consent
  • simultaneously participating in another drug or device study

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Study Group CFormula PTX Stent - Dose 3-
Study Group AFormula PTX Stent - Dose 1-
Study Group BFormula PTX Stent - Dose 2-
Primary Outcome Measures
NameTimeMethod
Percent Diameter Stenosis of the Treated Renal Artery9 months
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (12)

University Hospital Ostrava

🇨🇿

Ostrava-Poruba, Czechia

Royal Sussex County Hospital

🇬🇧

Brighton, United Kingdom

St. Bonifatius Hospital

🇩🇪

Lingen, Germany

Institute for Clinical and Experimental Medicine

🇨🇿

Prague, Czechia

Herz-Zentrum Bad Krozingen

🇩🇪

Bad Krozingen, Germany

Kent & Canterbury Hospital

🇬🇧

Canterbury, United Kingdom

Hopital Europeen Georges Pomidou

🇫🇷

Paris, France

St. Mary's Hospital

🇬🇧

London, United Kingdom

Klinik Dr. Hancken im Elbe Klinikum Stade

🇩🇪

Stade, Germany

Krankenhaus Neu-Bethlehem

🇩🇪

Göttingen, Germany

Uniklinik Heidelberg

🇩🇪

Heidelberg, Germany

Universitatsklinikum Leipzig AoR

🇩🇪

Leipzig, Germany

© Copyright 2025. All Rights Reserved by MedPath